Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Herpesvirus vectors in gene therapy.

Hukkanen V.

Open Virol J. 2010 Jun 18;4:94-5. doi: 10.2174/1874357901004030094. No abstract available.

2.

Development of herpesvirus-based episomally maintained gene delivery vectors.

Calderwood MA, White RE, Whitehouse A.

Expert Opin Biol Ther. 2004 Apr;4(4):493-505. Review.

PMID:
15102599
3.

Herpesvirus/retrovirus chimeric vectors.

Epstein AL, Manservigi R.

Curr Gene Ther. 2004 Dec;4(4):409-16. Review.

PMID:
15578990
4.

Herpesvirus saimiri: a potential gene delivery vector (review).

Whitehouse A.

Int J Mol Med. 2003 Feb;11(2):139-48.

PMID:
12525867
5.

Viral vectors for gene transfer: a review of their use in the treatment of human diseases.

Walther W, Stein U.

Drugs. 2000 Aug;60(2):249-71. Review.

PMID:
10983732
6.

Herpesvirus vectors come of age.

Hammerschmidt W.

Curr Opin Mol Ther. 2000 Oct;2(5):532-9. Review.

PMID:
11249756
7.

Biosafety of herpesvirus vectors.

Gogev S, Schynts F, Meurens F, Bourgot I, Thiry E.

Curr Gene Ther. 2003 Dec;3(6):597-611.

PMID:
14683454
8.

[Application of human herpesvirus (HHV)-6 and HHV-7 to the gene therapy vectors].

Kondo K.

Nihon Rinsho. 2006 Mar;64 Suppl 3:518-22. Review. Japanese. No abstract available.

PMID:
16615527
9.

Herpesvirus saimiri-based gene delivery vectors maintain heterologous expression throughout mouse embryonic stem cell differentiation in vitro.

Stevenson AJ, Clarke D, Meredith DM, Kinsey SE, Whitehouse A, Bonifer C.

Gene Ther. 2000 Mar;7(6):464-71.

11.

Epstein-Barr virus vectors for gene expression and transfer.

Sclimenti CR, Calos MP.

Curr Opin Biotechnol. 1998 Oct;9(5):476-9. Review.

PMID:
9821275
12.

[Herpes simplex type-1 virus-based vectors for gene therapy].

Ichikawa T, Saeki Y, Tamiya T, Chiocca EA, Ohmoto T.

Nihon Rinsho. 2000 Apr;58(4):822-7. Review. Japanese.

PMID:
10774201
13.

Biosafety of gene therapy vectors derived from herpes simplex virus type 1.

Lim F, Khalique H, Ventosa M, Baldo A.

Curr Gene Ther. 2013 Dec;13(6):478-91. Review.

PMID:
24397529
14.

Herpesvirus-mediated gene delivery into the rat brain: specificity and efficiency of the neuron-specific enolase promoter.

Andersen JK, Frim DM, Isacson O, Breakefield XO.

Cell Mol Neurobiol. 1993 Oct;13(5):503-15.

PMID:
8111822
15.

Novel gene therapy viral vector using non-oncogenic lymphotropic herpesvirus.

Shimizu A, Kobayashi N, Shimada K, Oura K, Tanaka T, Okamoto A, Kondo K.

PLoS One. 2013;8(2):e56027. doi: 10.1371/journal.pone.0056027.

16.

Marker gene transfer into human haemopoietic cells using a herpesvirus saimiri-based vector.

Doody GM, Leek JP, Bali AK, Ensser A, Markham AF, de Wynter EA.

Gene Ther. 2005 Feb;12(4):373-9.

PMID:
15616605
17.

Molecular genetic analysis of herpesviruses and their potential use as vectors for gene therapy applications.

Cotter MA, Robertson ES.

Curr Opin Mol Ther. 1999 Oct;1(5):633-44. Review.

PMID:
11249670
18.

Development and application of replication-incompetent HSV-1-based vectors.

Berto E, Bozac A, Marconi P.

Gene Ther. 2005 Oct;12 Suppl 1:S98-102. Review.

PMID:
16231061
19.

Construction of a gene inactivation library for Bovine herpesvirus 1 using infectious clone technology.

Mahony TJ, McCarthy FM, Gravel JL, Young PL.

Methods Mol Biol. 2005;292:387-400.

PMID:
15507722
20.

The potential of extrachromosomal replicating vectors for gene therapy.

Calos MP.

Trends Genet. 1996 Nov;12(11):463-6. Review.

PMID:
8973156
Items per page

Supplemental Content

Support Center